10 C.F.R. § 26.163
Link to an amendment published at 87 FR 71460, Nov. 22, 2022.
(a) Initial drug testing.
(1) HHS-certified laboratories shall apply the following cutoff levels for initial testing of specimens to determine whether they are negative for the indicated drugs and drug metabolites, except if validity testing indicates that the specimen is dilute or the licensee or other entity has established more stringent cutoff levels:
Initial Test Cutoff Levels for Drugs and Drug MetabolitesDrug or metabolites Cutoff level [nanograms (ng)/mL] Marijuana metabolites50 Cocaine metabolites300 Opiate metabolites2000 Phencyclidine (PCP)25 Amphetamines1000
(2) At the licensee's or other entity's discretion, as documented in the FFD program policies and procedures, the licensee or other entity may require the HHS-certified laboratory to conduct special analyses of dilute specimens as follows:
(b) Confirmatory drug testing.
(1) A specimen that is identified as positive on an initial drug test must be subject to confirmatory testing for the class(es) of drugs for which the specimen initially tested positive. The HHS-certified laboratory shall apply the confirmatory cutoff levels specified in this paragraph, except if the licensee or other entity requires the special analysis of dilute specimens permitted in paragraph (a)(2) of this section or the licensee or other entity has established more stringent cutoff levels.
Confirmatory Test Cutoff Levels for Drugs and Drug MetabolitesDrug or metabolites Cutoff level (ng/mL) Marijuana metabolite 115 Cocaine metabolite 2150 Opiates: Morphine2000 Codeine2000 6-acetylmorphine 310 Phencyclidine (PCP)25 Amphetamines: Amphetamine500 Methamphetamine 4500 1 As delta-9-tetrahydrocannabinol-9-carboxylic acid. 2 As benzoylecgonine. 3 Test for 6-AM when the confirmatory test shows a morphine concentration exceeding 2,000 ng/mL. 4 Specimen must also contain amphetamine at a concentration equal to or greater than 200 ng/mL.